Board of Directors, Scientific Founders

Luk is an associate professor at Harvard Medical School and associate member of the Broad Institute of Harvard and MIT. He directs the Grousbeck Gene Therapy Center at Massachusetts Eye and Ear Infirmary in Boston. He is a renowned scientific leader in AAV gene therapy research and development, and is a co-inventor of AAV9, a vector used in many gene therapies. He has authored more than 100 publications and holds more than a dozen licensed patents, mostly related to gene therapy methods, technologies, and applications. Luk is co-founder of the gene therapy companies Akouos (now part of Eli Lilly), Odylia, and GenSight Biologics. He received a Ph.D. in molecular medicine and an engineering degree at the University of Leuven, Belgium. Luk completed postgraduate training in translational cell and gene therapy at the University of Pennsylvania.